PTGER4基因多态性与山东汉族人群强直性脊柱炎易感性的关系
Association between PTGER4 gene polymorphism and susceptibility of ankylosing spondylitis in Han population in Shandong Province

DOI: 10.6040/j.issn.1671-7554.0.2016.022

Keywords: PTGER4,脊柱炎,多态性,病例对照研究,强直性,
Case-control study,Polymorphism,PTGER4,Ankylosing spondylitis

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Zambrano-Zaragoza JF, Agraz-Cibrian JM, Gonzalez-Reyes C, et al. Ankylosing spondylitis: from cells to genes[J]. Int J Inflam, 2013: 501653. doi: 10.1155/2013/501653.
[2]	Van der Heijde D, Kivitz A, Schiff MH, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial[J]. Arthritis Rheum, 2006, 54(7): 2136-2146.
[3]	Nedelec E, Abid A, Cipolletta C, et al. Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism[J]. Biochem Pharmacol, 2001, 61(8): 965-978.
[4]	Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondylo arthritis(part II): validation and final selection[J]. Ann Rheum Dis, 2009, 68(6): 777-783.
[5]	Niess JH, Brand S, Gu X, et al. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance[J]. Science, 2005, 307(5707): 254-258.
[6]	陈超, 李建军. IL-23/IL-17轴在强直性脊柱炎发病中的作用及治疗意义研究进展[J]. 天津医药, 2015, 43(10): 1213-1216. CHEN Chao, LI Jianjun. Roles of IL-23/IL-1 7 axis in pathogenesis and treatment of ankylosing spondylitis[J]. Tianjin Medical, 2015, 43(10): 1213-1216.
[7]	Honda T, Segi-Nishida E, Miyachi Y, et al. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis[J]. J Exp Med, 2006, 203(2): 325-335.
[8]	Wang C, Liao Q, Hu Y, et al. T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis[J]. Exp Ther Med, 2015, 9(1): 250-256.
[9]	Gaston JS, Goodall JC, Baeten D. Interleukin-23: a central cytokine in the pathogenesis of spondylarthritis[J]. Arthritis Rheum, 2011, 63(12): 3668-3671.
[10]	Braun J, Breban M, Maksymowych WP. Therapy for ankylosing spondylitis: new treatment modalities[J]. Best Pract Res Clin Rheumatol, 2002, 16(4): 631-651.
[11]	Libioulle C, Louis E, Hansoul S, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4[J]. PLoS Genet, 2007, 3(4): 58.
[12]	Chun KS, Akunda JK, Langenbach R. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4[J]. Cancer Res, 2007, 67(5): 2015-2021.
[13]	Burton PR, Clayton DG, Cardon LR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants[J]. Nature Genetics, 2007, 39(11): 1329-1337.
[14]	Mathies H. Diagnostic criteria in ankylosing spondylitis[J]. Dtsch Med Wochenschr, 1984, 109(10): 382-385.
[15]	Rudwaleit M, Landewe R, van der Heijde D, et al. The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondylo arthritis(part I): classification of paper patients by expert opinion including uncertainty appraisal[J]. Ann Rheum Dis, 2009, 68(6): 770-776.
[16]	吴珊珊, 段振华, 潘发明. 强直性脊柱炎流行病学研究进展[J]. 安徽医科大学学报, 2013, 48(8): 988-992.
[17]	Prijatelj M, Celhar T, Mlinaric-Rascan I. Prostaglandin EP4 receptor enhances BCR-induced apoptosis of immature B cells[J]. Prostaglandins Other Lipid Mediat, 2011, 95(1-4): 19-26.
[18]	Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion[J]. Nat Med, 2009, 15(6): 633-640.
[19]	Glas J, Seiderer J, Czamara D, et al. PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohns disease and affect NF-kappaB and XBP1 binding sites[J]. PLoS One, 2012, 7(12): 52873. doi:10.1371/journal.pone.0052873.
[20]	Perdigones N, Martin E, Robledo G, et al. Study of chromosomal region 5p13.1 in Crohns disease, ulcerative colitis, and rheumatoid arthritis[J]. Hum Immunol, 2010, 71(8): 826-828.
[21]	Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut[J]. J Clin Invest, 2002, 109(7): 883-893.
[22]	Diamond JM, Akimova T, Kazi A, et al. Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction[J]. Am J Respir Crit Care Med, 2014, 189(5): 567-575.
[23]	Chai W, Lian Z, Chen C, et al. JARID1A, JMY, and PTGER4 polymorphisms are related to ankylosing spondylitis in Chinese Han patients: a case-control study[J]. PLoS One, 2013, 8(9): 74794. doi:10.1371/journal.pone.0074794.
[24]	Wright PB, Mcentegart A, Mccarey D, et al. Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation[J]. Rheumatology(Oxford), 2016, 55(1): 120-132.
[25]	Jethwa H, Bowness P. The interleukin(IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment[J]. Clin Exp Immunol, 2016, 183(1):30-36.

Full-Text